The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Assessment of age in the clinical risk stratification of patients with IDH-mutant gliomas.
 
Michal Ziv
No Relationships to Disclose
 
Negar Sadeghipour
Employment - Caris Life Sciences
Travel, Accommodations, Expenses - Caris Life Sciences
 
Joanne Xiu
Employment - Caris Life Sciences
Travel, Accommodations, Expenses - Caris Life Sciences
 
Theodore Nicolaides
Employment - Caris Life Sciences
Stock and Other Ownership Interests - Caris Life Sciences
 
Manmeet Ahluwalia
Stock and Other Ownership Interests - doctible; MedInnovate Advisors LLC; MimiVax; TriSalus Life Sciences
Honoraria - Elsevier; Peerview; Prime Education; Prime Oncology
Consulting or Advisory Role - AlloVir; Anheart Therapeutics; Apollomics; Autem Therapeutics; Bayer; Bugworks; Cairn Therapeutics; Caris Life Sciences; Equillium; GlaxoSmithKline; InSightec; Janssen; Menarini Group; Modifi Bio; NH TherAguix; Nuvation Bio; Prelude Therapeutics; Pyramid Biosciences; SDP Oncology; Siemens Healhineers/Varian Medical Systems; Sumitomo Dainippon Pharma Oncology; ViewRay; Voyager Therapeutics; Xoft
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Merck (Inst); MimiVax (Inst); Novartis (Inst); Novocure (Inst); Pharmacyclics (Inst); Seagen (Inst)
Other Relationship - Idorsia (I); ResMed (I)
 
Michael Glantz
Research Funding - cns pharmaceuticals (Inst); Denovo Biopharma (Inst); European Organisation for Research and Treatment of Cancer (EORTC) (Inst); Five Prime Therapeutics (Inst); Genentech (Inst); ImmunoCellular Therapeutics (Inst); Ono Pharmaceutical (Inst); RTOG (Inst); Triphase Accelerator Corp (Inst)
 
Sonikpreet Aulakh
Honoraria - SERVIER
Consulting or Advisory Role - Caris Life Sciences; Novocure; PER; Spring works
Research Funding - Pfizer (Inst)
 
Katherine Peters
Consulting or Advisory Role - Anheart Therapeutics; Blue Earth Diagnostics; NuvOx Pharma; Ono Pharmaceutical; Rigel; Sapience Therapeutics; SERVIER; Telix Pharmaceuticals
Research Funding - BioMimetix; Novocure; NuvOx Pharma; Ono Pharmaceutical; Sapience Therapeutics; SERVIER; Varian Medical Systems
Other Relationship - Eisai Europe
(OPTIONAL) Uncompensated Relationships - Vivacitas Oncology